89(top 1%)
papers
2.7K(top 1%)
citations
31(top 1%)
h-index
51(top 1%)
g-index
95
all documents
3.0K
doc citations
598
citing journals

Top Articles

#TitleJournalYearCitations
1ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosisMultiple Sclerosis Journal2018458
2Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort studyLancet Neurology, The2020219
3Defining reliable disability outcomes in multiple sclerosisBrain2015162
4Predictors of long‐term disability accrual in relapse‐onset multiple sclerosisAnnals of Neurology2016158
5Switch to natalizumab versus fingolimod in active relapsing–remitting multiple sclerosisAnnals of Neurology2015143
6Towards personalized therapy for multiple sclerosis: prediction of individual treatment responseBrain201794
7Outcome measurement in functional neurological disorder: a systematic review and recommendationsJournal of Neurology, Neurosurgery and Psychiatry202077
8A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patientsMultiple Sclerosis Journal201669
9Environmental Factors Associated with Disease Progression after the First Demyelinating Event: Results from the Multi-Center SET StudyPLoS ONE201368
10Video-polysomnography procedures for diagnosis of rapid eye movement sleep behavior disorder (RBD) and the identification of its prodromal stages: guidelines from the International RBD Study GroupSleep202264
11Reliable measurements of brain atrophy in individual patients with multiple sclerosisBrain and Behavior201658
12Complement activation in patients with neuromyelitis opticaJournal of Neuroimmunology201454
13Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker StudiesMultiple Sclerosis International201152
14Risk of secondary progressive multiple sclerosis: A longitudinal studyMultiple Sclerosis Journal202052
15Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosisJournal of Neurology, Neurosurgery and Psychiatry201749
16Separate neural representations of depression, anxiety and apathy in Parkinson’s diseaseScientific Reports201749
17Distinct populations of neurons respond to emotional valence and arousal in the human subthalamic nucleusProceedings of the National Academy of Sciences of the United States of America201548
18Resting-state functional magnetic resonance imaging of the subthalamic microlesion and stimulation effects in Parkinson's disease: Indications of a principal role of the brainstemNeuroImage: Clinical201546
19Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndromeJournal of Neurology201445
20Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patientsJournal of Lipid Research201545
21Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's diseaseNeuroImage: Clinical201843
22Serum neurofilament light chain reflects inflammation-driven neurodegeneration and predicts delayed brain volume loss in early stage of multiple sclerosisMultiple Sclerosis Journal202141
23Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?Multiple Sclerosis Journal201739
24Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosisMultiple Sclerosis Journal201739
25Fine‐Mapping of SNCA in Rapid Eye Movement Sleep Behavior Disorder and Overt SynucleinopathiesAnnals of Neurology202039
26Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months laterMultiple Sclerosis Journal201637
27Auditory dysfunction in patients with Huntington’s diseaseClinical Neurophysiology201737
28Seroprevalence and specificity of NMO-IgG (anti-aquaporin 4 antibodies) in patients with neuropsychiatric systemic lupus erythematosusRheumatology International201336
29Chasing shadows: What determines DTI metrics in gray matter regions? An in vitro and in vivo studyJournal of Magnetic Resonance Imaging201336
30Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing–remitting multiple sclerosisMultiple Sclerosis Journal201536
31Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosisMultiple Sclerosis Journal201836
32The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosisMultiple Sclerosis Journal201634
33Contribution of different relapse phenotypes to disability in multiple sclerosisMultiple Sclerosis Journal201730
34Clinicopathological description of two cases with SQSTM1 gene mutation associated with frontotemporal dementiaNeuropathology201626
35Early predictors of non-response to interferon in multiple sclerosisActa Neurologica Scandinavica201222
36Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimodMultiple Sclerosis and Related Disorders201822
37A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long‐Term Comparative StudyJournal of Neuroimaging201720
38Impact of dopamine and cognitive impairment on neural reactivity to facial emotion in Parkinson's diseaseEuropean Neuropsychopharmacology201920
39Prevalence and evolution of spasticity in patients suffering from first‐ever stroke with carotid origin: a prospective, longitudinal studyEuropean Journal of Neurology201920
40Evaluation of a Multiparametric Immunofluorescence Assay for Standardization of Neuromyelitis Optica SerologyPLoS ONE201219
41Frequency-phase analysis of resting-state functional MRIScientific Reports201718
42Methods for automatic detection of artifacts in microelectrode recordingsJournal of Neuroscience Methods201718
43Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practiceMultiple Sclerosis Journal201718
44Effects of Menopause in Women With Multiple Sclerosis: An Evidence-Based ReviewFrontiers in Neurology202118
45Moving towards Integrated and Personalized Care in Parkinson’s Disease: A Framework Proposal for Training Parkinson NursesJournal of Personalized Medicine202118
46Hypothalamo–pituitary–adrenal axis, glucose metabolism and TNF‐α in narcolepsyJournal of Sleep Research201417
47Influence of nationality on the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)Clinical Neuropsychologist201817
48Unraveling corticobasal syndrome and alien limb syndrome with structural brain imagingCortex201917
49Quantitative brain MR imaging in amyotrophic lateral sclerosisMagnetic Resonance Materials in Physics, Biology, and Medicine201110
50Motor Matters: Tackling Heterogeneity of Parkinson’s Disease in Functional MRI StudiesPLoS ONE201310